| First Author | Hosono-Fukao T | Year | 2012 |
| Journal | Am J Pathol | Volume | 180 |
| Issue | 5 | Pages | 2056-67 |
| PubMed ID | 22429964 | Mgi Jnum | J:183381 |
| Mgi Id | MGI:5318608 | Doi | 10.1016/j.ajpath.2012.01.015 |
| Citation | Hosono-Fukao T, et al. (2012) Heparan Sulfate Subdomains that are Degraded by Sulf Accumulate in Cerebral Amyloid ss Plaques of Alzheimer's Disease: Evidence from Mouse Models and Patients. Am J Pathol 180(5):2056-67 |
| abstractText | Alzheimer's disease (AD) is characterized by extracellular cerebral accumulation of amyloid beta peptide (Abeta). Heparan sulfate (HS) is a glycosaminoglycan that is abundant in the extracellular space. The state of sulfation within the HS chain influences its ability to interact with a variety of proteins. Highly sulfated domains within HS are crucial for Abeta aggregation in vitro. Here, we investigated the expression of the sulfated domains and HS disaccharide composition in the brains of Tg2576, J20, and T41 transgenic AD mouse models, and patients with AD. RB4CD12, a phage display antibody, recognizes highly sulfated domains of HS. The RB4CD12 epitope is abundant in the basement membrane of brain vessels under physiological conditions. In the cortex and hippocampus of the mice and patients with AD, RB4CD12 strongly stained both diffuse and neuritic amyloid plaques. Interestingly, RB4CD12 also stained the intracellular granules of certain hippocampal neurons in AD brains. Disaccharide compositions in vessel-enriched and nonvasculature fractions of Tg2576 mice and AD patients were found to be comparable to those of non-transgenic and non-demented controls, respectively. The RB4CD12 epitope in amyloid plaques was substantially degraded ex vivo by Sulf-1 and Sulf-2, extracellular HS endosulfatases. These results indicate that formation of highly sulfated HS domains may be upregulated in conjunction with AD pathogenesis, and that these domains can be enzymatically remodeled in AD brains. |
